We are Inventia Life Science (www.inventia.life) and we are radically changing the way the world treats disease and injury. We're a multidisciplinary team, deeply inspired by the purpose of innovating for the better and backed by top-tier venture capital funds.

The current team sits at just under 50. Our revolutionary 3D digital bioprinting technology enables pioneers in the fields of drug discovery and medicine to radically drive innovation from disease treatment (in areas such as cancer) through to the way we treat injuries. 

We are actively growing our team in all areas of expertise - from engineering to go-to-market functions. We have offices in Australia, US, and Europe, and will be tripling our global headcount in the coming 2 years.